Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roflumilast: the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 15, Issue 1, Pages 85-96
Publisher
Informa Healthcare
Online
2013-09-14
DOI
10.1517/14656566.2013.837159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDE4 in the human heart - major player or little helper?
- (2013) Thomas Eschenhagen BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype
- (2013) Jadwiga A. Wedzicha et al. CHEST
- Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
- (2013) Joy Miller et al. RESPIRATORY MEDICINE
- Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
- (2013) Donald P Tashkin et al. RESPIRATORY RESEARCH
- Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
- (2013) Yevgeniy Samyshkin et al. International Journal of Chronic Obstructive Pulmonary Disease
- Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro
- (2012) J Milara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Novel Antiinflammatory Therapies for COPD
- (2012) Nicholas J. Gross CHEST
- Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality
- (2012) Prasadini N. Perera et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
- (2012) Yuji Oba et al. Therapeutic Advances in Respiratory Disease
- Inhaler device selection: Special considerations in elderly patients with chronic obstructive pulmonary disease
- (2011) R. Barrons et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Inhaler mishandling remains common in real life and is associated with reduced disease control
- (2011) Andrea S. Melani et al. RESPIRATORY MEDICINE
- Lung function impairment, COPD hospitalisations and subsequent mortality
- (2011) J. Garcia-Aymerich et al. THORAX
- Chronic Obstructive Pulmonary Disease Phenotypes
- (2010) MeiLan K. Han et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Genetic Epidemiology of COPD (COPDGene) Study Design
- (2010) Elizabeth A. Regan et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
- (2010) John R. Hurst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
- (2009) Leonardo M Fabbri et al. LANCET
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
- (2009) Peter MA Calverley et al. LANCET
- Pharmacologic Treatments for Chronic Obstructive Pulmonary Disease: A Mixed-Treatment Comparison Meta-analysis
- (2009) William L Baker et al. PHARMACOTHERAPY
- Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
- (2008) J. Vestbo et al. EUROPEAN RESPIRATORY JOURNAL
- Outcomes for COPD pharmacological trials: from lung function to biomarkers
- (2008) M. Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
- Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease
- (2008) M. Bradley Drummond et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
- (2008) Donald P. Tashkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: A randomized placebo-controlled trial
- (2008) Jens M. Hohlfeld et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Effect of fluticasone propionate/salmeterol (250/50μg) or salmeterol (50μg) on COPD exacerbations
- (2008) Gary T. Ferguson et al. RESPIRATORY MEDICINE
- Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice
- (2008) Piero A Martorana et al. BMC Pulmonary Medicine
- The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide
- (2007) Jadwiga A. Wedzicha et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started